Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus

Search Close Search

Print

2021 RESEARCH

- Archives -

Video capsule endoscopy safe, effective alternative for diagnosing GI bleeding during COVID-19

Video capsule endoscopy safe, effective alternative for diagnosing GI bleeding during COVID-19

David Cave, MD, PhD, and colleagues at UMass Medical School found that using video capsule endoscopy as a first procedure for the detection of the source of acute gastrointestinal bleeding could be a safe and effective alternative to the traditional method.

M2D2 $200K Challenge names biomedical innovation contest winners

M2D2 $200K Challenge names biomedical innovation contest winners

UMass Medical School and UMass Lowell announced the winners of the 2021 Massachusetts Medical Device Development Center $200K Challenge. Acoustica Bio, a startup aiming to transform how patients receive intravenous medications, is the top winner.

UMMS establishes gene therapy collaborative research agreement with Pfizer

UMMS establishes gene therapy collaborative research agreement with Pfizer

UMass Medical School has entered into a three-year, collaborative research agreement with Pfizer to evaluate determinants that influence the manufacturing quality and yield of viral vectors used in gene therapy. The research at UMMS is being performed under the direction of Guangping Gao, PhD, and Dan Wang, PhD.

Erik Sontheimer co-leading efforts to develop gene editing toolkit by NIH Somatic Cell Genome Editing Consortium

Erik Sontheimer co-leading efforts to develop gene editing toolkit by NIH Somatic Cell Genome Editing Consortium

Six UMass Medical School scientists are among the members of the National Institutes of Health’s Somatic Cell Genome Editing Consortium to publish a paper in Nature outlining the program’s goals.

UMass Medical School helps lead NIH RADx to accelerate new COVID test technologies

UMass Medical School helps lead NIH RADx to accelerate new COVID test technologies

The national effort to bring convenient, affordable and rapid testing technology for SARS-CoV-2 infection to market is moving full speed ahead. The $1.5 billion effort was launched a year ago, with UMass Medical School playing a major role in coordinating the push for fast, accessible COVID-19 testing.

New study of oral therapy candidate indicates positive results for patients with mild-to-moderate COVID-19

New study of oral therapy candidate indicates positive results for patients with mild-to-moderate COVID-19

New research by Kaleido Biosciences, Inc., and UMass Medical School’s John P. Haran, MD, PhD, and Beth McCormick, PhD, shows that the company’s microbiome metabolic therapy candidate produced positive results in patients with mild-to-moderate COVID-19.

PhD student Catherine Nagawa examining link between social networks, smoking cessation with new NIH award

PhD student Catherine Nagawa examining link between social networks, smoking cessation with new NIH award

PhD student Catherine Nagawa received a National Institutes of Health Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research.

Video: Preventive shot for Lyme disease, now in clinical trial, explained

Video: Preventive shot for Lyme disease, now in clinical trial, explained

A pre-exposure prophylaxis to prevent Lyme disease, developed at MassBiologics of UMass Medical School and now being tested in a year-long human clinical trial, could be ready for licensure in about two and a half years, according to Mark Klempner, MD.

UMass MIND awarded drama therapy grant by National Endowment of the Arts

UMass MIND awarded drama therapy grant by National Endowment of the Arts

Xiaoduo Fan, MD, MPH, is principal investigator of a collaboration between UMass MIND and Lesley University to investigate virtual drama therapy for individuals recovering from serious mental illness, who often do not respond to conventional treatment methods.

Innovative neurosurgical technique used in Tay-Sachs gene therapy clinical trial

Innovative neurosurgical technique used in Tay-Sachs gene therapy clinical trial

Oguz Cataltepe, MD, describes the innovative neurosurgical procedure used to treat patients in the new clinical trial for a gene therapy targeting infantile Tay-Sachs and Sandhoff diseases.

Showing 1-10 of 32 items
of 4